Skip to content

Safety and efficacy of dual-coil and single coil implantable cardioverter-defibrillator leads

Comparison of safety and efficacy of dual-coil and single coil leads in patients with implantable cardioverter-defibrillator

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201202011965N3
Enrollment
200
Registered
2012-06-28
Start date
2012-04-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardioversion-Defibrillation. Cardiac arrest with successful resuscitation

Interventions

Intervention 1: Single coil defibrillation leads: defibrillator lead with single coil located in the distal portion of the lead. In this setting, distal RV coil serves as anode and Active Can as catho
Treatment - Devices
Single coil defibrillation leads: defibrillator lead with single coil located in the distal portion of the lead. In this setting, distal RV coil serves as anode and Active Can as cathode.
Dual coil defibrillation leads: defibrillator lead with both proximal and distal coils. In this configuration, distal coil serves as anode and Active Can-proximal SVC coil serves as cathode

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Standard indications for implantable cardioverter-defibrillator implantation and Exclusion criteria: ventricular arrhythmia due to a reversible cause; life expectancy < 12 months due to other medical conditions; tricuspid valve prosthesis; redo procedure

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Lead pacing paramters and defibrillation threhsold testing. Timepoint: 1, 6, and 12 months. Method of measurement: Programmer.

Secondary

MeasureTime frame
Number of successful ICD interventions, mortality related to high DFT, and lead complications. Timepoint: 1, 6, and 12 months. Method of measurement: History, physical exam, chest x-ray, and programmer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Majid Haghjoo

Cardiac Electrophysiology Research Center

majid.haghjoo@gmail.com+98 21 2392 2163

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026